Search Results for: SFTPD

12 interactions involving SFTPD - surfactant protein D found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel CCN1 cellular communication network factor 1
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
Novel GPA33 glycoprotein A33
Novel KCNMA1 potassium calcium-activated channel subfamily M alpha 1
  • Ca2+ activated K+ channels
  • cGMP effects
  • Sensory processing of sound by inner hair cells of the cochlea
  • Acetylcholine inhibits contraction of outer hair cells
  • Chlorzoxazone
  • Bendroflumethiazide
  • Procaine
  • Hydroflumethiazide
  • Ritodrine
  • Hydrochlorothiazide
  • Nitrendipine
  • Miconazole
  • Diazoxide
  • Halothane
  • Colforsin
  • Dequalinium
  • Trimebutine
Novel LBR lamin B receptor
  • Cholesterol biosynthesis
  • Initiation of Nuclear Envelope (NE) Reformation
  • RHOA GTPase cycle
  • RHOC GTPase cycle
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOG GTPase cycle
  • RAC3 GTPase cycle
  • Regulation of MECP2 expression and activity
  • HEM skeletal dysplasia; Greenberg dysplasia
  • Pelger-Huet anomaly
Novel PLAU plasminogen activator, urokinase
  • Neutrophil degranulation
  • Dissolution of Fibrin Clot
  • Amiloride
  • 2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide
  • 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine
  • 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine
  • 2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine
  • 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine
  • 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
  • CRA_10655
  • 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
  • 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
  • 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide
  • 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide
  • Benzamidine
  • 4-Iodobenzo[B]Thiophene-2-Carboxamidine
  • CRA_8696
  • Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine
  • 2-Amino-1H-benzimidazol-5-ol
  • N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea
  • 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine
  • Thieno[2,3-B]Pyridine-2-Carboxamidine
  • 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide
  • [2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine
  • Fibrinolysin
  • 6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine
  • 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE
  • N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE
  • 6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE
  • 1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine
  • (2R)-1-(2,6-dimethylphenoxy)propan-2-amine
  • 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide
  • 4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide
  • 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE
  • 4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide
Novel PLXNA3 plexin A3
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • CRMPs in Sema3A signaling
Novel RBX1 ring-box 1
  • Recognition of DNA damage by PCNA-containing replication complex
  • Prolactin receptor signaling
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Vif-mediated degradation of APOBEC3G
  • Degradation of beta-catenin by the destruction complex
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Degradation of DVL
  • Degradation of GLI1 by the proteasome
  • Degradation of GLI2 by the proteasome
  • GLI3 is processed to GLI3R by the proteasome
  • Hedgehog 'on' state
  • Regulation of RAS by GAPs
  • DNA Damage Recognition in GG-NER
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
  • Formation of TC-NER Pre-Incision Complex
  • Transcription-Coupled Nucleotide Excision Repair (TC-NER)
  • Dual incision in TC-NER
  • Gap-filling DNA repair synthesis and ligation in TC-NER
  • Orc1 removal from chromatin
  • Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A
  • FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
  • Regulation of RUNX2 expression and activity
  • Neddylation
  • Regulation of expression of SLITs and ROBOs
  • Interleukin-1 signaling
  • Negative regulation of NOTCH4 signaling
  • Potential therapeutics for SARS
  • Regulation of BACH1 activity
  • Nuclear events stimulated by ALK signaling in cancer
  • KEAP1-NFE2L2 pathway
  • GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Evasion by RSV of host interferon responses
  • GSK3B-mediated proteasomal degradation of PD-L1(CD274)
  • SPOP-mediated proteasomal degradation of PD-L1(CD274)
  • Degradation of CRY and PER proteins
  • Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide
Novel SFTPA1 surfactant protein A1
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signal regulatory protein family interactions
  • Surfactant metabolism
  • Regulation of TLR by endogenous ligand
  • Defective CSF2RB causes SMDP5
  • Defective CSF2RA causes SMDP4
  • 2-(N-morpholino)ethanesulfonic acid
Novel SMR3B submaxillary gland androgen regulated protein 3B
DCN decorin
  • Degradation of the extracellular matrix
  • Glycosaminoglycan-protein linkage region biosynthesis
  • CS-GAG biosynthesis
  • DS-GAG biosynthesis
  • CS/DS degradation
  • ECM proteoglycans
  • ECM proteoglycans
  • Defective B4GALT7 causes EDS, progeroid type
  • Defective B3GAT3 causes JDSSDHD
  • Defective CHST3 causes SEDCJD
  • Defective CHST14 causes EDS, musculocontractural type
  • Defective CHSY1 causes TPBS
  • Defective B3GALT6 causes EDSP2 and SEMDJL1
  • Congenital stromal corneal dystrophy (CSCD); Congenital hereditary stromal dystrophy; Witschel dystrophy
DMBT1 deleted in malignant brain tumors 1
  • Surfactant metabolism
MFAP4 microfibril associated protein 4
  • Molecules associated with elastic fibres

Page 1 out of 1 pages